U.S. Market for Psoriasis Cream and Medication 2009
The psoriasis treatment market includes all over-the-counter and prescription pharmaceutical products used to treat psoriasis. This includes topical tar, salicylic acid, corticosteroids, combination corticosteroids, vitamin D analogs, anthralin, retinoids, methotrexate, cyclosporine, and biologic treatments. Over the forecast period, the market is estimated to increase at double digit rates.
LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
1.1 PSORIASIS TREATMENT MARKET
1.2 PSORIASIS TREATMENT UTILIZATION
1.3 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
2.2.1 Step 1: Project Initiation & Team Selection
2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
2.2.4 Step 4: Performing Primary Research
2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
2.2.6 Step 6: Market Forecast and Analysis
2.2.7 Step 7: Identify Strategic Opportunities
2.2.8 Step 8: Final Review and Market Release
2.2.9 Step 9: Customer Feedback and Market Monitoring
PSORIASIS CREAM AND MEDICATION MARKET
3.1 INTRODUCTION
3.1.1 Status of Pharmacotherapy in Psoriasis
3.1.1.1 Topical Treatments
3.1.1.2 Non-Biologic Systemic Treatments18
3.1.1.3 Biologic Systemic Treatments..20
3.2 MARKET OVERVIEW
3.2.1 Psoriasis Patient Population
3.2.1.1 Number of Treatments per Patient
3.2.2 Psoriasis Treatment Utilization
3.2.3 Psoriasis Treatment Prices
3.3 MARKET ANALYSIS AND FORECAST
3.3.1 Combined Market
3.3.2 Market for Topical Psoriasis Treatments
3.3.3 Market for Biologic Treatments.
3.3.4 Market for Non-Biologic Systemic Treatments
3.4 MARKET DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE ANALYSIS
3.5.1 Total Psoriasis Treatment Competitive Analysis
3.5.2 Topical Treatment Competitive Analysis
3.5.3 Biologic Treatment Competitive Analysis.
3.5.4 Non-Biologic Systemic Treatment Competitive Analysis
LIST OF FIGURES
EXECUTIVE SUMMARY
RESEARCH METHODOLOGY.
PSORIASIS CREAM AND MEDICATION MARKET
Figure 3-1: Psoriasis Patient Population, U.S., 2005 – 2005
Figure 3-2: Psoriasis Patient Population by Disease Severity, U.S., 2005 – 2015
Figure 3-3: Diagnosis Rates by Psoriasis Severity, U.S., 2005 – 2015
Figure 3-4: Psoriasis Severity Treatment Rates, U.S., 2005 – 2015
Figure 3-5: Number of Treatments per Patient by Psoriasis Severity, U.S., 2005 – 2015
Figure 3-6: Psoriasis Treatment Utilization Frequency, U.S., 2005 – 2015
Figure 3-7: Psoriasis Treatment Annual Prices by Treatment Type, U.S., 2005 – 2015
Figure 3-8: Psoriasis Treatment Monthly Prices by Treatment Type, U.S., 2005 – 2015
Figure 3-9: Total Market for Psoriasis Treatments, U.S., 2005 – 2015
Figure 3-10: Total Market for Psoriasis Treatments by Treatment Type, U.S., 2005 – 2015
Figure 3-11: Market for Topical Psoriasis Treatments, U.S., 2005 – 2015
Figure 3-12: Market for Topical Psoriasis Treatments by Treatment Type, U.S., 2005 – 2015
Figure 3-13: Market for Biologic Psoriasis Treatments, U.S., 2005 – 2015
Figure 3-14: Market for Non-Biologic Systemic Psoriasis Treatments, U.S., 2005 – 2015
Figure 3-15: Market for Non-Biologic Systemic Psoriasis Treatments by Treatment Type, U.S., 2005 – 2015
Figure 3-16: Drivers and Limiters, Psoriasis Market, U.S., 2008
Figure 3-17: Leading Competitors in the Total Psoriasis Treatment Market, U.S., 2008
Figure 3-18: Leading Competitors in the Prescription Topical Psoriasis Treatment Market, U.S., 2008
Figure 3-19: Leading Competitors in the Biologic Psoriasis Treatment Market, U.S., 2008
Figure 3-20: Leading Competitors in the Non-Biologic Systemic Psoriasis Treatment Market, U.S., 2008
LIST OF CHARTS
EXECUTIVE SUMMARY
Chart 1-1: Anti-Adhesion Product Market, U.S., 2005 – 2015
Chart 1-2: Psoriasis Treatment Utilization, U.S., 2008
Chart 1-3: Leading Competitors in the Psoriasis Treatment Market, U.S., 2008
RESEARCH METHODOLOGY.
PSORIASIS CREAM AND MEDICATION MARKET
Chart 3-1: Psoriasis Patient Population by Disease Severity, U.S., 2008
Chart 3-2: Psoriasis Patient Population by Disease Severity, U.S., 2005 – 2015
Chart 3-3: Number of Treatments per Patient by Psoriasis Severity, U.S., 2005 – 2015
Chart 3-4: Psoriasis Treatment Utilization Frequency, U.S., 2008
Chart 3-5: Psoriasis Treatment Utilization Frequency, U.S., 2015
Chart 3-6: Psoriasis Treatment Annual Prices by Treatment Type, U.S., 2008
Chart 3-7: Total Market for Psoriasis Treatments, U.S., 2005 – 2015
Chart 3-8: Total Market for Psoriasis Treatments by Treatment Type, U.S., 2008 (US$ Millions)
Chart 3-9: Total Market for Psoriasis Treatments by Treatment Type, U.S., 2015 (US$ Millions)
Chart 3-10: Market for Topical Psoriasis Treatments, U.S., 2005 – 2015
Chart 3-11: Market for Topical Psoriasis Treatments by Treatment Type, U.S., 2008 (US$ Millions)
Chart 3-12: Market for Topical Psoriasis Treatments by Treatment Type, U.S., 2015 (US$ Millions)
Chart 3-13: Market for Biologic Psoriasis Treatments, U.S., 2005 – 2015
Chart 3-14: Market for Non-Biologic Systemic Psoriasis Treatments, U.S., 2005 – 2015
Chart 3-15: Market for Non-Biologic Systemic Psoriasis Treatments by Treatment Type, U.S., 2008
Chart 3-16: Market for Non-Biologic Systemic Psoriasis Treatments by Treatment Type, U.S., 2015 (US$ Millions)
Chart 3-17: Leading Competitors in the Total Psoriasis Treatment Market, U.S., 2008
Chart 3-18: Leading Competitors in the Prescription Topical Psoriasis Treatment Market, U.S., 2008
Chart 3-19: Leading Competitors in the Biologic Psoriasis Treatment Market, U.S., 2008
Chart 3-20: Leading Competitors in the Non-Biologic Systemic Psoriasis Treatment Market, U.S., 2008
EXECUTIVE SUMMARY
1.1 PSORIASIS TREATMENT MARKET
1.2 PSORIASIS TREATMENT UTILIZATION
1.3 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
2.2.1 Step 1: Project Initiation & Team Selection
2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
2.2.4 Step 4: Performing Primary Research
2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
2.2.6 Step 6: Market Forecast and Analysis
2.2.7 Step 7: Identify Strategic Opportunities
2.2.8 Step 8: Final Review and Market Release
2.2.9 Step 9: Customer Feedback and Market Monitoring
PSORIASIS CREAM AND MEDICATION MARKET
3.1 INTRODUCTION
3.1.1 Status of Pharmacotherapy in Psoriasis
3.1.1.1 Topical Treatments
3.1.1.2 Non-Biologic Systemic Treatments18
3.1.1.3 Biologic Systemic Treatments..20
3.2 MARKET OVERVIEW
3.2.1 Psoriasis Patient Population
3.2.1.1 Number of Treatments per Patient
3.2.2 Psoriasis Treatment Utilization
3.2.3 Psoriasis Treatment Prices
3.3 MARKET ANALYSIS AND FORECAST
3.3.1 Combined Market
3.3.2 Market for Topical Psoriasis Treatments
3.3.3 Market for Biologic Treatments.
3.3.4 Market for Non-Biologic Systemic Treatments
3.4 MARKET DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE ANALYSIS
3.5.1 Total Psoriasis Treatment Competitive Analysis
3.5.2 Topical Treatment Competitive Analysis
3.5.3 Biologic Treatment Competitive Analysis.
3.5.4 Non-Biologic Systemic Treatment Competitive Analysis
LIST OF FIGURES
EXECUTIVE SUMMARY
RESEARCH METHODOLOGY.
PSORIASIS CREAM AND MEDICATION MARKET
Figure 3-1: Psoriasis Patient Population, U.S., 2005 – 2005
Figure 3-2: Psoriasis Patient Population by Disease Severity, U.S., 2005 – 2015
Figure 3-3: Diagnosis Rates by Psoriasis Severity, U.S., 2005 – 2015
Figure 3-4: Psoriasis Severity Treatment Rates, U.S., 2005 – 2015
Figure 3-5: Number of Treatments per Patient by Psoriasis Severity, U.S., 2005 – 2015
Figure 3-6: Psoriasis Treatment Utilization Frequency, U.S., 2005 – 2015
Figure 3-7: Psoriasis Treatment Annual Prices by Treatment Type, U.S., 2005 – 2015
Figure 3-8: Psoriasis Treatment Monthly Prices by Treatment Type, U.S., 2005 – 2015
Figure 3-9: Total Market for Psoriasis Treatments, U.S., 2005 – 2015
Figure 3-10: Total Market for Psoriasis Treatments by Treatment Type, U.S., 2005 – 2015
Figure 3-11: Market for Topical Psoriasis Treatments, U.S., 2005 – 2015
Figure 3-12: Market for Topical Psoriasis Treatments by Treatment Type, U.S., 2005 – 2015
Figure 3-13: Market for Biologic Psoriasis Treatments, U.S., 2005 – 2015
Figure 3-14: Market for Non-Biologic Systemic Psoriasis Treatments, U.S., 2005 – 2015
Figure 3-15: Market for Non-Biologic Systemic Psoriasis Treatments by Treatment Type, U.S., 2005 – 2015
Figure 3-16: Drivers and Limiters, Psoriasis Market, U.S., 2008
Figure 3-17: Leading Competitors in the Total Psoriasis Treatment Market, U.S., 2008
Figure 3-18: Leading Competitors in the Prescription Topical Psoriasis Treatment Market, U.S., 2008
Figure 3-19: Leading Competitors in the Biologic Psoriasis Treatment Market, U.S., 2008
Figure 3-20: Leading Competitors in the Non-Biologic Systemic Psoriasis Treatment Market, U.S., 2008
LIST OF CHARTS
EXECUTIVE SUMMARY
Chart 1-1: Anti-Adhesion Product Market, U.S., 2005 – 2015
Chart 1-2: Psoriasis Treatment Utilization, U.S., 2008
Chart 1-3: Leading Competitors in the Psoriasis Treatment Market, U.S., 2008
RESEARCH METHODOLOGY.
PSORIASIS CREAM AND MEDICATION MARKET
Chart 3-1: Psoriasis Patient Population by Disease Severity, U.S., 2008
Chart 3-2: Psoriasis Patient Population by Disease Severity, U.S., 2005 – 2015
Chart 3-3: Number of Treatments per Patient by Psoriasis Severity, U.S., 2005 – 2015
Chart 3-4: Psoriasis Treatment Utilization Frequency, U.S., 2008
Chart 3-5: Psoriasis Treatment Utilization Frequency, U.S., 2015
Chart 3-6: Psoriasis Treatment Annual Prices by Treatment Type, U.S., 2008
Chart 3-7: Total Market for Psoriasis Treatments, U.S., 2005 – 2015
Chart 3-8: Total Market for Psoriasis Treatments by Treatment Type, U.S., 2008 (US$ Millions)
Chart 3-9: Total Market for Psoriasis Treatments by Treatment Type, U.S., 2015 (US$ Millions)
Chart 3-10: Market for Topical Psoriasis Treatments, U.S., 2005 – 2015
Chart 3-11: Market for Topical Psoriasis Treatments by Treatment Type, U.S., 2008 (US$ Millions)
Chart 3-12: Market for Topical Psoriasis Treatments by Treatment Type, U.S., 2015 (US$ Millions)
Chart 3-13: Market for Biologic Psoriasis Treatments, U.S., 2005 – 2015
Chart 3-14: Market for Non-Biologic Systemic Psoriasis Treatments, U.S., 2005 – 2015
Chart 3-15: Market for Non-Biologic Systemic Psoriasis Treatments by Treatment Type, U.S., 2008
Chart 3-16: Market for Non-Biologic Systemic Psoriasis Treatments by Treatment Type, U.S., 2015 (US$ Millions)
Chart 3-17: Leading Competitors in the Total Psoriasis Treatment Market, U.S., 2008
Chart 3-18: Leading Competitors in the Prescription Topical Psoriasis Treatment Market, U.S., 2008
Chart 3-19: Leading Competitors in the Biologic Psoriasis Treatment Market, U.S., 2008
Chart 3-20: Leading Competitors in the Non-Biologic Systemic Psoriasis Treatment Market, U.S., 2008
